Clinical Trial Update: Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pharmacokinetics and local exposure characteristics of FX006 in patients with osteoarthritis of the knee; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2018-01-12